z-logo
open-access-imgOpen Access
AB052. P-20. Phase 2, open-label study of second-line M7824 treatment in patients with locally advanced or metastatic biliary tract cancer
Author(s) -
Mitesh J. Borad,
Milind Javle,
Junji Furuse,
ChihHung Hsu,
Markus Moehler,
DoYoun Oh,
Joon Oh Park,
Lin Shen,
Juan W. Valle,
Meng Li,
Christoph Helwig,
John Bridgewater
Publication year - 2019
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.ab052
Subject(s) - medicine , biliary tract cancer , biliary tract , oncology , second line , gastroenterology , cancer , first line , gemcitabine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom